The TMF Reference Model standardized filing, not interpretation
[see also part 1 of this series]
In the previous article, I argued that clinical trials today share a number of characteristics with international banking before the introduction of SWIFT. The industry has become increasingly interconnected, yet a significant amount of operational effort remains focused on review, reconciliation, interpretation, and inspection readiness. Before discussing how this situation may evolve, it is worth recognising that the industry has already solved one major standardisation challenge, and it has solved it remarkably well.
The Trial Master File Reference Model is arguably one of the most successful standardisation initiatives in clinical research. Prior to its introduction, sponsors, CROs, and other participants often maintained their own filing conventions, naming schemes, and organisational structures. Documents with identical purposes could be stored in different locations, classified differently, or grouped according to local preferences. Collaboration across organisational boundaries was more difficult, outsourcing created additional complexity, and inspection preparation often required significant effort simply to understand how a study had been organised.
The introduction of the TMF Reference Model brought order to this situation. It established a common filing structure, a common vocabulary, and a common understanding of where different categories of documents belong. As a result, organisations could exchange documentation more easily, inspections became more predictable, and the industry gained a shared framework for organising trial documentation. Few would dispute that this represented a significant step forward in the maturity of clinical research.
It is important, however, to understand precisely what problem the TMF Reference Model was designed to solve. At its core, it is a filing standard. It provides guidance on the classification and organisation of artefacts within a Trial Master File. It helps determine where documents belong, who is responsible for maintaining them, and how they can be located efficiently during inspections or operational reviews. These are important objectives, and the TMF Reference Model achieves them exceptionally well.
What the TMF Reference Model does not attempt to do is standardise the interpretation of the information contained within those artefacts. Nor was it designed to. The objective was to establish a common filing structure, not a common interpretation framework. Whether such a framework would even be desirable is a separate question, one that the industry has only recently begun to explore.
A delegation log remains a delegation log regardless of where it is filed. An informed consent form remains an informed consent form whether it resides in Veeva, Florence, SharePoint, or a paper archive. The filing location may be standardised, but the meaning and significance of the information contained within the document remain subject to human interpretation.
This distinction only became apparent to me once I understood how quality control is actually performed. Consider a delegation log. The industry broadly agrees what a delegation log is, where it should be filed, who is responsible for maintaining it, and when it should be available for inspection. Yet sponsors, CROs, auditors, and inspectors continue to spend considerable effort reviewing delegation logs. The challenge is rarely locating the document. The challenge is determining what the document actually demonstrates and whether that demonstration is sufficient.
Questions quickly emerge. Are all required signatures present? Are the dates internally consistent? Do delegated responsibilities align with training records and qualifications? Were study activities performed by individuals who were authorised to perform them at that point in time? Does the document support inspection readiness? None of these questions are answered by the filing structure itself. They require interpretation of the contents of the artefact and, in many cases, interpretation of how that artefact relates to other artefacts.
The same observation applies across much of the Trial Master File. Training records, informed consent forms, temperature logs, investigator qualifications, equipment calibration records, and countless other artefacts are routinely reviewed not because organisations struggle to locate them, but because organisations must determine what those artefacts actually demonstrate. The industry has become highly effective at standardising document placement. It remains heavily dependent on human interpretation when assessing document meaning. In other words, organisations rarely review artefacts because they cannot locate them. They review artefacts because somebody must determine what those artefacts prove.
This situation is not unique to clinical research. The banking industry encountered a remarkably similar challenge after introducing standardised financial messages. Standardising message formats improved communication substantially. However, banks soon discovered that exchanging the same message did not guarantee that different institutions would process, interpret, or validate that message in the same way. Standardisation of structure proved necessary, but it did not prove sufficient.
Clinical research may be approaching a similar realisation. The TMF Reference Model has provided the industry with a common filing structure and has helped establish a common language for document organisation. Yet many of the most expensive and labour-intensive activities in clinical operations continue to revolve around interpretation, reconciliation, and validation. This suggests that the industry’s next challenge may not be where artefacts are stored, but how their contents are understood consistently across independent participants.
If the last two decades focused on standardising where documents belong, an obvious question emerges for the next decade. How can sponsors, CROs, sites, auditors, and regulators arrive at a more consistent interpretation of the information contained within those documents? Until that question is addressed, quality control will remain largely dependent on human review, reconciliation will remain a recurring activity, and inspection readiness will remain predominantly retrospective.
The challenge is no longer finding documents. The challenge is establishing a more consistent understanding of what those documents demonstrate.
One Reply to “”